Slideset: Early Induction Therapy for IBD

Learn about current guideline recommendations for the treatment of moderate to severe UC and CD, including the rationale for combination therapy.
Bruce E. Sands, MD, MS
Format: Microsoft PowerPoint (.ppt)
File Size: 581 KB
Released: April 26, 2021

Acknowledgements

Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Bristol-Myers Squibb

Related Content

Expert commentary from Dr. Millie Long on developing “activated” patients with IBD in your practice, from Clinical Care Options (CCO)

Millie D. Long, MD, MPH Released: July 13, 2021

Downloadable slides covering best practices of shared-decision making and discussing cancer risk when discussing initiation of biologic therapy with patients who have IBD

Millie D. Long, MD, MPH Released: June 24, 2021

Interactive video from Dr. Millie Long and Clinical Care Options (CCO) on implementing shared decision-making in IBD management

Millie D. Long, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: June 23, 2021 Expired: June 22, 2022

Expert commentary from Dr. Bruce Sands on therapeutic drug monitoring in IBD, from Clinical Care Options (CCO)

Bruce E. Sands, MD, MS Released: June 3, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue